UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 42

Sortiert nach

Pulse wave velocity as index of arterial stiffness in HIV-infected patients compared with a healthy population

Journal of acquired immune deficiency syndromes (1999), 2014-01, Vol.65 (1), p.50

2014

Volltextzugriff (PDF)

High-level dolutegravir resistance selection on dolutegravir/lamivudine

Clinical infectious diseases, 2024-03

2024

Volltextzugriff (PDF)

Virological, Immunological, and Clinical Impact of Switching from Protease Inhibitors to Nevirapine or to Efavirenz in Patients with Human Immunodeficiency Virus Infection and Long-Lasting Viral Suppression

Clinical infectious diseases, 2002-02, Vol.34 (4), p.504-510

2002

Volltextzugriff (PDF)

Ability of treatment week 12 viral response to predict long-term outcome in genotype 1 hepatitis C virus/HIV coinfected patients

AIDS (London), 2010-04, Vol.24 (7), p.975-982

2010

Volltextzugriff (PDF)

Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study

The lancet HIV, 2021-11, Vol.8 (11), p.e701-e710

2021

Volltextzugriff (PDF)

Impact of tenofovir on SARS-CoV-2 infection and severe outcomes among people living with HIV: a propensity score-matched study

Journal of antimicrobial chemotherapy, 2022-07, Vol.77 (8), p.2265-2273

2022

Volltextzugriff (PDF)

Mortality and immunovirological outcomes in patients with advanced HIV disease on their first antiretroviral treatment: differential impact of antiretroviral regimens

Journal of antimicrobial chemotherapy, 2023-01, Vol.78 (1), p.108-116

2023

Volltextzugriff (PDF)

Evaluation of the Innate Immune Modulator Acitretin as a Strategy To Clear the HIV Reservoir

Antimicrobial agents and chemotherapy, 2017-11, Vol.61 (11)

2017

Volltextzugriff (PDF)

Sustained Virological Response to Interferon Plus Ribavirin Reduces Non—Liver-Related Mortality in Patients Coinfected With HIV and Hepatitis C Virus

Clinical infectious diseases, 2012-09, Vol.55 (5), p.728-736

2012

Volltextzugriff (PDF)

Predictors of poor health‐related quality of life among people living with HIV aged ≥60 years in the PISCIS cohort: Findings from the Vive+ project

HIV medicine, 2024-04, Vol.25 (4), p.424-439

2024

Volltextzugriff (PDF)

Prevalence and factors associated with liver steatosis as measured by transient elastography with controlled attenuation parameter in HIV-infected patients

AIDS (London), 2014-06, Vol.28 (9), p.1279-1287

2014

Volltextzugriff (PDF)

Short-term Treatment With Interferon Alfa Diminishes Expression of HIV-1 and Reduces CD4+T-Cell Activation in Patients Coinfected With HIV and Hepatitis C Virus and Receiving Antiretroviral Therapy

The Journal of infectious diseases, 2016-03, Vol.213 (6), p.1008-1012

2016

Volltextzugriff (PDF)

Real-world evidence of the effectiveness of ombitasvir-paritaprevir/r ± dasabuvir ± ribavirin in patients monoinfected with chronic hepatitis C or coinfected with human immunodeficiency virus-1 in Spain

PloS one, 2019-11, Vol.14 (11), p.e0225061

2019

Volltextzugriff (PDF)

Early but limited effects of raltegravir intensification on CD4 T cell reconstitution in HIV-infected patients with an immunodiscordant response to antiretroviral therapy

Journal of antimicrobial chemotherapy, 2013-10, Vol.68 (10), p.2358-2362

2013

Volltextzugriff (PDF)

Short-term Treatment With Interferon Alfa Diminishes Expression of HIV-1 and Reduces CD4 super(+) T-Cell Activation in Patients Coinfected With HIV and Hepatitis C Virus and Receiving Antiretroviral Therapy

The Journal of infectious diseases, 2016-03, Vol.213 (6), p.1008-1012

2016

Volltextzugriff (PDF)

Optimal Use of Transient Elastography and Acoustic Radiation Force Impulse to Stage Liver Fibrosis in HIV/HCV‐Coinfected Patients in Clinical Practice

Journal of ultrasound in medicine, 2018-01, Vol.37 (1), p.113-121

2018

Volltextzugriff (PDF)

Incidence of hepatocellular carcinoma in HIV-infected patients with cirrhosis: a prospective study

Journal of acquired immune deficiency syndromes (1999), 2014-01, Vol.65 (1), p.82

2014

Volltextzugriff (PDF)

Changes in T-cell subsets in HIV-HCV-coinfected patients during pegylated interferon-α2a plus ribavirin treatment

Antiviral therapy, 2010-04, Vol.15 (3), p.333-342

2010

Volltextzugriff (PDF)

Effect of liver fibrosis on long-term mortality in HIV/hepatitis C virus-coinfected individuals who are evaluated to receive interferon therapies in the highly active antiretroviral therapy era

AIDS research and human retroviruses, 2012-10, Vol.28 (10), p.1235

2012

Volltextzugriff (PDF)

The natural history of liver cirrhosis in HIV-hepatitis C virus-coinfected patients

AIDS (London), 2011-04, Vol.25 (7), p.899-904

2011

Volltextzugriff (PDF)

Efficacy of Low-Dose Subcutaneous Interleukin-2 to Treat Advanced Human Immunodeficiency Virus Type 1 in Persons with ⩽250/μL CD4 T Cells and Undetectable Plasma Virus Load

The Journal of infectious diseases, 1999-07, Vol.180 (1), p.56-60

1999

Volltextzugriff (PDF)

Effect of an induction period of pegylated interferon-α2a and ribavirin on early virological response in HIV-HCV-coinfected patients: results from the CORAL-2 study

Antiviral therapy, 2011, Vol.16 (6), p.833-841

2011

Volltextzugriff (PDF)

Safety and efficacy of an induction dose of pegylated interferon alpha-2a on early hepatitis C virus kinetics in HIV/HCV co-infected patients: the CORAL-1 multicentre pilot study

Journal of viral hepatitis, 2007-10, Vol.14 (10), p.704-713

2007

Volltextzugriff (PDF)

Distribution of CD31 on CD4 T-Cells from Cord Blood, Peripheral Blood and Tonsil at Different Stages of Differentiation

The open immunology journal, 2010-01, Vol.3, p.19-26

2010

Volltextzugriff (PDF)

Changes in T-cell subsets in HIV-HCV-coinfected patients during pegylated interferon-alpha2a plus ribavirin treatment

Antiviral therapy, 2010, Vol.15 (3), p.333-342

2010

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(34)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(24)
Science & Technology
(24)
Infectious Diseases
(23)
Life Sciences & Biomedicine
(23)
Female
(18)
Immunology
(16)
Male
(16)
Adult
(15)
Hiv Infections - Drug Therapy
(15)
Hiv
(13)
Biological And Medical Sciences
(12)
Human Immunodeficiency Virus
(12)
Medical Sciences
(12)
Microbiology
(12)
Human Viral Diseases
(11)
Middle Aged
(11)
Viral Diseases
(11)
Virology
(11)
Hiv Infections - Complications
(10)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(10)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

8 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pulse wave velocity as index of arterial stiffness in HIV-infected patients compared with a healthy population

High-level dolutegravir resistance selection on dolutegravir/lamivudine

Virological, Immunological, and Clinical Impact of Switching from Protease Inhibitors to Nevirapine or to Efavirenz in Patients with Human Immunodeficiency Virus Infection and Long-Lasting Viral Suppression

Ability of treatment week 12 viral response to predict long-term outcome in genotype 1 hepatitis C virus/HIV coinfected patients

Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study

Impact of tenofovir on SARS-CoV-2 infection and severe outcomes among people living with HIV: a propensity score-matched study

Mortality and immunovirological outcomes in patients with advanced HIV disease on their first antiretroviral treatment: differential impact of antiretroviral regimens

Evaluation of the Innate Immune Modulator Acitretin as a Strategy To Clear the HIV Reservoir

Sustained Virological Response to Interferon Plus Ribavirin Reduces Non—Liver-Related Mortality in Patients Coinfected With HIV and Hepatitis C Virus

Predictors of poor health‐related quality of life among people living with HIV aged ≥60 years in the PISCIS cohort: Findings from the Vive+ project

Prevalence and factors associated with liver steatosis as measured by transient elastography with controlled attenuation parameter in HIV-infected patients

Short-term Treatment With Interferon Alfa Diminishes Expression of HIV-1 and Reduces CD4+T-Cell Activation in Patients Coinfected With HIV and Hepatitis C Virus and Receiving Antiretroviral Therapy

Real-world evidence of the effectiveness of ombitasvir-paritaprevir/r ± dasabuvir ± ribavirin in patients monoinfected with chronic hepatitis C or coinfected with human immunodeficiency virus-1 in Spain

Early but limited effects of raltegravir intensification on CD4 T cell reconstitution in HIV-infected patients with an immunodiscordant response to antiretroviral therapy

Short-term Treatment With Interferon Alfa Diminishes Expression of HIV-1 and Reduces CD4 super(+) T-Cell Activation in Patients Coinfected With HIV and Hepatitis C Virus and Receiving Antiretroviral Therapy

Optimal Use of Transient Elastography and Acoustic Radiation Force Impulse to Stage Liver Fibrosis in HIV/HCV‐Coinfected Patients in Clinical Practice

Incidence of hepatocellular carcinoma in HIV-infected patients with cirrhosis: a prospective study

Changes in T-cell subsets in HIV-HCV-coinfected patients during pegylated interferon-α2a plus ribavirin treatment

Effect of liver fibrosis on long-term mortality in HIV/hepatitis C virus-coinfected individuals who are evaluated to receive interferon therapies in the highly active antiretroviral therapy era

The natural history of liver cirrhosis in HIV-hepatitis C virus-coinfected patients

Efficacy of Low-Dose Subcutaneous Interleukin-2 to Treat Advanced Human Immunodeficiency Virus Type 1 in Persons with ⩽250/μL CD4 T Cells and Undetectable Plasma Virus Load

Effect of an induction period of pegylated interferon-α2a and ribavirin on early virological response in HIV-HCV-coinfected patients: results from the CORAL-2 study

Safety and efficacy of an induction dose of pegylated interferon alpha-2a on early hepatitis C virus kinetics in HIV/HCV co-infected patients: the CORAL-1 multicentre pilot study

Distribution of CD31 on CD4 T-Cells from Cord Blood, Peripheral Blood and Tonsil at Different Stages of Differentiation

Changes in T-cell subsets in HIV-HCV-coinfected patients during pegylated interferon-alpha2a plus ribavirin treatment

Suchergebnisse filtern